WVE financials
Wave Life Sciences (WVE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
WVE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $42.73M | $33.88M | -$215.38M | -$204.38M | -1.21 |
| 2024 | $108.30M | $108.30M | -$110.40M | -$97.01M | -0.70 |
| 2023 | $113.31M | $113.31M | -$68.00M | -$57.51M | -0.54 |
| 2022 | $3.65M | $3.65M | -$162.72M | -$161.82M | -2.05 |
| 2021 | $40.96M | $40.96M | -$127.02M | -$122.25M | -2.36 |
| 2020 | $20.08M | -$110.87M | -$153.38M | -$149.91M | -3.82 |
- WVE revenue was $42.73M in fiscal 2025, net income -$204.38M.
Updated 2026-11-02 17:55 UTC